RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 23-33
  • A new era of testing [Commentary]

    A new era of testing [Commentary]
    Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits. The presence of these...
  • 9th Circuit bans juror exclusion over sexual orientation

    SAN FRANCISCO — A federal appeals court became the first in the nation to rule that prospective jurors may not be excluded because of their sexual orientation, a decision that expands juror protections beyond race and gender and provides legal...
  • Looking Out: Jurors can't be excluded based on sexual orientation, court says

    Looking Out: Jurors can't be excluded based on sexual orientation, court says
    In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations. Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
  • Illinois among 45 states settling off-label dispute with GlaxoSmithKline

    Illinois among 45 states settling off-label dispute with GlaxoSmithKline
    The Illinois Attorney General on Wednesday announced the state was part of a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that the company unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin....
  • The week in review: scams, refunds, recalls and other consumer news you need to know

     
    Happy Monday! If you're looking for good news, you've come to the wrong place. If you want the dirt on the latest scams, accusations of fraud, recalls and other consumer news, read on for a summary of what the Watchdog......
  • State AG sues maker of diabetes drugs for false advertising

    State AG sues maker of diabetes drugs for false advertising
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
  • China trying to pull back on gift-giving

    BEIJING — If you want a full-time teaching job, but you're stuck in a temporary gig without health benefits, Luo Chunlei advises that you buy the school principal a box of mooncakes and follow up with an envelope of dough. Having an operation?...
  • Looking Out: Court deciding if sexual orientation can impact jury selection

    Looking Out: Court deciding if sexual orientation can impact jury selection
    Despite numerous marriage equality-related cases currently making their way through the judicial system, it's somehow the hot-button area of antitrust law where an important LGBT rights issue is taking place. The Associated Press reported Wednesday that...
  • Athletes only too happy to be 'lab rats'

    Athletes only too happy to be 'lab rats'
    After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound. But the failed experimental drug, called GW501516, is making a comeback in another...
  • Pointing to threat, pulling in profit

    Pointing to threat, pulling in profit
    WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...